Agrylin

Agrylin

anagrelide

Manufacturer:

Fahrenheit
Concise Prescribing Info
Contents
Anagrelide HCl
Indications/Uses
Patients w/ thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count & the risk of thrombosis & to ameliorate associated symptoms including thrombohemorrhagic events.
Dosage/Direction for Use
Initially, 0.5 mg 4 times daily or 1 mg twice daily for at least 1 wk. Dose may be increased by not more than 0.5 mg/day in any 1 wk. Max dose: 10 mg/day or 2.5 mg as a single dose.
Administration
May be taken with or without food.
Contraindications
Pregnancy.
Special Precautions
Known or suspected CV disorders, renal insufficiency, hepatic dysfunction. Monitor blood counts, liver & renal functions. Lactation. Childn <16 yr.
Adverse Reactions
CHF, MI, cardiomyopathy, cardiomegaly, complete heart block, atrial fibrillation, CVA, pericarditis, pulmonary infiltrates, pulmonary fibrosis, pulmonary hypertension, pancreatitis, gastric/duodenal ulcer, seizure. Asthenia, fever, headache, malaise, abdominal pain, palpitations, tachycardia, GI disturbances, edema, dizziness, paraesthesia, cough, dyspnea, pharyngitis, pruritus, rash.
ATC Classification
L01XX35 - anagrelide ; Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
Agrylin cap 0.5 mg
Packing/Price
100's (Rp5,000,000/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in